The Scientist

» FDA and microbiology

Most Recent

image: Nanobombs Terminate Foodborne Microbes

Nanobombs Terminate Foodborne Microbes

By | March 5, 2015

Researchers engineer water nanostructures to wipe out pathogens that can spoil food and pose health risks.

2 Comments

image: HHS Rolls Out Public Access Plans

HHS Rolls Out Public Access Plans

By | March 3, 2015

The US Department of Health and Human Services outlines how the National Institutes of Health and its other agencies will make research results public.

0 Comments

image: Tough-to-Clean Equipment a Bigger Problem

Tough-to-Clean Equipment a Bigger Problem

By | March 2, 2015

The number of deaths attributable to certain medical probes may go beyond a recent outbreak in Los Angeles.

2 Comments

image: Of Cells and Limits

Of Cells and Limits

By | March 1, 2015

Leonard Hayflick has been unafraid to speak his mind, whether it is to upend a well-entrenched dogma or to challenge the federal government. At 86, he’s nowhere near retirement.

3 Comments

image: FDA OKs 23andMe Test

FDA OKs 23andMe Test

By | February 20, 2015

The US Food and Drug Administration will allow the personal genomics company to resume a disease-risk analysis.

0 Comments

image: Medical Equipment May Spread Superbug

Medical Equipment May Spread Superbug

By | February 20, 2015

Drug-resistant bacteria have spread in a Los Angeles hospital, perhaps from contaminated endoscopes.

1 Comment

image: Clinic Trial Problems Kept Mum

Clinic Trial Problems Kept Mum

By | February 11, 2015

Despite documented dysfunction in a number of studies, rarely do those problems get a mention in the resulting publications, according to a new study.

0 Comments

image: Subway Microbiome

Subway Microbiome

By | February 9, 2015

Researchers document the bacterial life living among New York City’s transit stations.

0 Comments

image: FDA Head Leaving Post

FDA Head Leaving Post

By | February 6, 2015

US Food and Drug Administration commissioner Margaret Hamburg is stepping down after six years on the job.

0 Comments

image: Lazarus Drugs

Lazarus Drugs

By | February 1, 2015

While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.  

1 Comment

Popular Now

  1. Publishers’ Legal Action Advances Against Sci-Hub
  2. Metabolomics Data Under Scrutiny
    Daily News Metabolomics Data Under Scrutiny

    Out of 25,000 features originally detected by metabolic profiling of E. coli, fewer than 1,000 represent unique metabolites, a study finds.

  3. How Microbes May Influence Our Behavior
  4. Do Microbes Trigger Alzheimer’s Disease?
AAAS